← Back to Search

Abstinence Period for Male Infertility

N/A
Recruiting
Led By Jonathan Gal, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days, 5 days, 2 days, 1 day, 3 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to find out if shorter abstinence periods improve sperm quality in healthy men.

Who is the study for?
This trial is for healthy men aged 20-45 who can provide a semen sample and have a sperm count of at least 1 million with high DNA fragmentation. It's not for those with low sperm counts, normal DNA fragmentation, significant health issues, or no semen production.
What is being tested?
The study examines how different periods of sexual abstinence (7 days, 5 days, 2 days, 1 day, and 3 hours) affect the quality of semen in participants by analyzing samples provided after each interval.
What are the potential side effects?
There are typically no side effects associated with abstaining from sexual activity for short periods and providing semen samples through masturbation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days, 5 days, 2 days, 1 day, 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days, 5 days, 2 days, 1 day, 3 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in semen analysis parameters based on different abstinence periods: motility
Change in semen analysis parameters based on different abstinence periods: sperm concentration
Change in semen analysis parameters based on different abstinence periods: volume
Secondary study objectives
Change in sperm DNA fragmentation based on different abstinence periods

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy VolunteersExperimental Treatment1 Intervention
Healthy males with no significant comorbidities, aged 20-45 years who are able to produce a semen sample by masturbation.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,091 Previous Clinical Trials
1,154,646 Total Patients Enrolled
Jonathan Gal, MDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
70 Total Patients Enrolled
Jessica Marinaro, MDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
70 Total Patients Enrolled

Media Library

Healthy Volunteers Clinical Trial Eligibility Overview. Trial Name: NCT05701163 — N/A
Male Infertility Research Study Groups: Healthy Volunteers
Male Infertility Clinical Trial 2023: Healthy Volunteers Highlights & Side Effects. Trial Name: NCT05701163 — N/A
Healthy Volunteers 2023 Treatment Timeline for Medical Study. Trial Name: NCT05701163 — N/A
~65 spots leftby Feb 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top